Jeffrey del Carmen - 28 Jun 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role: Chief Commercial Officer
Signature: /s/ Jeffrey Del Carmen
Issuer symbol: CPRX
Transactions as of: 28 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 30 Jun 2022, 17:00:34 UTC
Previous filing: 16 Feb 2022
Next filing: 22 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CPRX	Common stock, par value $0.001 per share	Options Exercise		+10,000	+141%		17,070	28 Jun 2022	Direct	F1
transaction	CPRX	Common stock, par value $0.001 per share	Tax liability		-2,930	-17%		14,140	28 Jun 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CPRX	Restricted Stock Units	Options Exercise	$0	-10,000	-1.3%	$0.000000	747,000	28 Jun 2022	Common Stock	10,000		Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2	Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
F3	Derivative securities vest in equal tranches, 1/3rd on June 23, 2021, 1/3rd on June 23, 2022, and 1/3rd on June 23, 2023.
F4	Shares of common stock will be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on June 28, 2022.